E-LIB Suche - Ergebnisse für: Hoban, Megan D.

1

Fertility-preserving myeloablative conditioning using singl..:

Uchida, Naoya ; Stasula, Ulana ; Demirci, Selami...
Nature Communications. 14 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

2

Editing the Sickle Cell Disease Mutation in Human Hematopoi..:

Romero, Zulema ; Lomova, Anastasia ; Said, Suzanne...
Molecular Therapy. 27 (2019) 8 - p. 1389-1406 , 2019

Link: https://doi.org/10.1016/..

3

Mgta-456, Cord Blood CD34+ Cells Expanded with an Aryl Hydr..:

Goncalves, Kevin A. ; Hoban, Megan D. ; Proctor, Jennifer L....
Biology of Blood and Marrow Transplantation. 24 (2018) 3 - p. S115-S116 , 2018

Link: https://doi.org/10.1016/..

4

Characterization of Gene Alterations following Editing of t..:

Long, Joseph ; Hoban, Megan D. ; Cooper, Aaron R....
Molecular Therapy. 26 (2018) 2 - p. 468-479 , 2018

Link: https://doi.org/10.1016/..

5

Phenotype Does not Always Equal Function: HDAC Inhibitors a..:

Goncalves, Kevin A. ; Hoban, Megan D. ; Proctor, Jennifer L....
Biology of Blood and Marrow Transplantation. 24 (2018) 3 - p. S479 , 2018

Link: https://doi.org/10.1016/..

6

Site-Specific Gene Editing of Human Hematopoietic Stem Cell..:

Kuo, Caroline Y. ; Long, Joseph D. ; Campo-Fernandez, Beatriz...
Cell Reports. 23 (2018) 9 - p. 2606-2616 , 2018

Link: https://doi.org/10.1016/..

7

Aryl Hydrocarbon Receptor Antagonists Expand Adult Hematopo..:

Hoban, Megan D. ; Goncalves, Kevin A. ; Proctor, Jennifer L....
Biology of Blood and Marrow Transplantation. 24 (2018) 3 - p. S477 , 2018

Link: https://doi.org/10.1016/..

8

A Non-Genotoxic Antibody Drug Conjugate Targeting C-Kit for..:

Hartigan, Adam J. ; Pearse, Brad R. ; McDonough, Sean M....
Biology of Blood and Marrow Transplantation. 24 (2018) 3 - p. S47-S48 , 2018

Link: https://doi.org/10.1016/..

9

118. Characterization of Chromosomal Alterations Using a Zi..:

Long, Joseph ; Hoban, Megan D. ; Kuo, Caroline Y....
Molecular Therapy. 24 (2016) - p. S49 , 2016

Link: https://doi.org/10.1016/..

10

CRISPR/Cas9-Mediated Correction of the Sickle Mutation in H..:

Hoban, Megan D ; Lumaquin, Dianne ; Kuo, Caroline Y...
Molecular Therapy. 24 (2016) 9 - p. 1561-1569 , 2016

Link: https://doi.org/10.1038/..

11

Delivery of Genome Editing Reagents to Hematopoietic Stem/P..:

Hoban, Megan D. ; Romero, Zulema ; Cost, Gregory J....
Current Protocols in Stem Cell Biology. 36 (2016) 1 - p. , 2016

Link: https://doi.org/10.1002/..

12

Analyzing CRISPR genome-editing experiments with CRISPResso:

Pinello, Luca ; Canver, Matthew C ; Hoban, Megan D...
Nature Biotechnology. 34 (2016) 7 - p. 695-697 , 2016

Link: https://doi.org/10.1038/..

13

338. Evaluation of TALENs and the CRISPR/Cas9 Nuclease Syst..:

Hoban, Megan D. ; Lumaquin, Dianne ; Kuo, Caroline...
Molecular Therapy. 23 (2015) - p. S135 , 2015

Link: https://doi.org/10.1016/..

14

115. Correction of the Sickle-Cell Disease Mutation in Huma..:

Hoban, Megan D. ; Mendel, Matthew C. ; Romero, Zulema...
Molecular Therapy. 23 (2015) - p. S48 , 2015

Link: https://doi.org/10.1016/..

15

121. Targeted Gene Therapy in the Treatment of X-Linked Hyp..:

Kuo, Caroline Y. ; Hoban, Megan D. ; Joglekar, Alok V....
Molecular Therapy. 23 (2015) - p. S50 , 2015

Link: https://doi.org/10.1016/..